Author:
Huang Xiaoling,Lin Rong,Liu Huan,Dai Mengying,Guo Jiejie,Hui Wenjia,Liu Weidong,Haerken Milamuguli,Zheng Ruixue,Yushanjiang Tangnuer,Gao Feng
Funder
Natural Science Foundation of Xinjiang Uygur Autonomous Region
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Gajendran, M., P. Loganathan, G. Jimenez, A.P. Catinella, N. Ng, C. Umapathy, N. Ziade, and J.G. Hashash. 2019. A comprehensive review and update on ulcerative colitis(). Disease-a-month 65 (12): 100851.
2. Du, L., and C. Ha. 2020. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterology Clinics of North America 49 (4): 643–654.
3. Kucharzik, T., S. Koletzko, K. Kannengiesser, and A. Dignass. 2020. Ulcerative Colitis-Diagnostic and Therapeutic Algorithms. Deutsches Ärzteblatt International 117 (33–34): 564–574.
4. Porter R.J., R. Kalla, and G.T. Ho. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Research vol. 9 F1000 Faculty Rev-294. 24 Apr. 2020. https://doi.org/10.12688/f1000research.20805.1
5. Shi, F., X. Guo, X. Jiang, P. Zhou, Y. Xiao, T. Zhou, G. Chen, Z. Zhao, H. Xiao, C. Hou, et al. 2012. Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis. Clinical Immunology (Orlando, Fla) 145 (3): 230–240.